PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

Anti-Cancer Drugs

Volumn 20, Issue 1, 2009, Pages 59-64

  Li, Dan ^a   Qu, Xiujuan ^a   Hou, Kezuo ^a   Zhang, Ye ^a   Dong, Qian ^a   Teng, Yuee ^a   Zhang, Jingdong ^a   Liu, Yunpeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Bufalin; Casitas B lineage lymphoma proteins; Gastric cancer

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BUFALIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BUFANOLIDES; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; MORPHOLINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-CBL; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TIME FACTORS;

EID: 57349119864     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3283160fd6     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49:33-64.
2. Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry 1998; 48:1-29.
3. Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 1995; 19:549-556.
4. Yin JQ, Shen JN, Su WW, Wang J, Huang G, Jin S, et al. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300- resistant cell lines. Acta Pharmacol Sin 2007; 28:712-720.
5. Yeh JY, Huang WJ, Kan SF, Wang PS. Effect of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2003; 54:112-124.
6. Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 1996; 271:14067-14072.
7. Tian X, Luo Y, Liu YP, Hou KZ, Jin B, Zhang JD, et al. Downregulation of Bcl-2 and survivin expression and release of Smac/DIABLO involved in bufalin-induced HL-60 cell apoptosis. Zhonghua Xue Ye Xue Za Zhi 2006; 27:21-24.
8. Liu Y, Qu X, Wang P, Tian X, Luo Y, Liu S, et al. WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin. Zhonghua Xue Ye Xue Za Zhi 2002; 23:356-359.
9. Tian X, Wang PP, Liu YP, Hou KZ, Jin B, Luo Y, et al. Effect of bufalininducing apoptosis on Bcl-2 and PKC in HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007; 15:67-71.
10. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 2001; 21:952-965.
11. Yuan ZQ, Sun M, Feldman Rl, Wang G, Ma X, Jiang C, et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 2000; 19:2324-2330.
12. Page C, Huang M, Jin X, Cho K, Lilja J, Reynolds RK, et al. Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells. Int J Oncol 2000; 17:23-28.
13. Hemmings BA. Akt signaling: linking membrane events to life and death decisions. Science 1997; 275:628-630.
14. Cardone MH, Roy N, Stennicke HR, Safvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282:1318-1321.
15. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serinethreonine kinase. Nature 1999; 401:82-85.
16. El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res 2006; 66:10553-10559.
17. Kwon MJ, Nam TJ. A polysaccharide of the marine alga Capsosiphon fulvescens induces apoptosis in AGS gastric cancer cells via an IGF-IR- mediated PI3K/Akt pathway. Cell Biol Int 2007; 31:768-775.
18. Moon DO, Park SY, Choi YH, Kim ND, Lee C, Kim GY. Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 2008; 51:112-120.
19. Watabe M, Ito K, Masuda Y, Nakajo S, Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 1998; 16:779-787.
20. Kawazoe N, Watabe M, Masuda Y, Nakajo S, Nakaya K. Tiam 1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 1999; 18:2413-2421.
21. Jing Y, Watabe M, Hashimoto S, Nakajo S, Nakaya K. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res 1994; 14:1193-1198.
22. Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 2007; 3:7-17.
23. Jeong SJ, Dasgupta A, Jung KJ, Urn JH, Burke A, Park HU, et al. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1 -transformed cells. Virology 2008; 370:264-272.
24. Fan XM, Jiang XH, Gu Q, Ching YP, He H, Xia HH, et al. Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells. Digestion 2006; 73:75-83.
25. Ostrakhovitch EA, Cherian MG. Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: the lack of effect of ERK in p53 mediated copper induced apoptosis. J Cell Biochem 2005; 95:1120-1134.
26. Kang CD, Yoo SD, Hwang BW, Kim KW, Kim DW, Kim CM, et al. The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells. Leuk Res 2000; 24:527-534.
27. Wang S, Liu YP, Hou KZ, Wang Y, Ye W. Bufalin-induced apoptosis through inhibition of ERK signal and downregulation of TOPO-αα in K562 cells. Chinese J Cancer Prev Treat 2006; 22:1701-1703.
28. Kyo S, Sada K, Qu X, Maeno K, Miah SM, Kawauchi-Kamata K, et al. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon Rl-mediated mast cell activation. Genes Cells 2003; 8:825-836.
29. Qu X, Sada K, Kyo S, Maeno K, Miah SM, Yamamura H. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 2004; 103:1779-1786.
30. Thien CB, Langdon WY. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem J 2005; 391:153-166.
31. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 1996; 12:839-846.
32. Fang D, Liu YC. Proteolysis-independent regulation of PI3K by Cbl-bmediated ubiquitination in T cells. Wat Immunol 2001; 2:870-875.
33. Qu X, Liu Y, Ma Y, Zhang Y, Li Y, Hou K. Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation. Biochem Biophys Res Commun 2008; 367:183-189.